首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Medicine >The efficacy of spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a meta-analysis
【2h】

The efficacy of spleen-preserving distal pancreatectomy with or without splenic vessel preservation: a meta-analysis

机译:保留脾脏或不保留脾血管的远端脾切除术的疗效:荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Spleen-preserving distal pancreatectomy can be performed with splenic vessel preservation (SPDP-SVP) or splenic vessel resection (SPDP-SVR). This meta-analysis aimed to evaluate the clinical outcomes of patients undergoing SPDP-SVP or SPDP-SVR. Method: A systematic literature search of PubMed, Embase, and the Cochrane Library was performed. The operative time, estimated blood loss, postoperative complications, pancreatic fistula (Grade B+C) rates, splenic infarction rates, gastric/perigastric varices rates and postoperative hospital stay were evaluated. RevMan 5.3 software was used to evaluate the differences between groups. Results: Nine studies involving 639 patients were included in this meta-analysis, of whom 402 underwent SPDP-SVP and 237 underwent SPDP-SVR. Patients who underwent SPDP-SVP had lower splenic infarction and gastric/perigastric varices rates. The operative time, estimated blood loss, postoperative complications, pancreatic fistula (Grade B+C) rates and postoperative hospital stays were comparable between these two groups. Conclusions: SPDP-SVP and SPDP-SVR are both safe, feasible procedures for the management of benign or low-grade malignant pancreatic body or tail tumors. However, SPDP-SVR is related to higher incidence rates of early splenic ischemia and gastric/perigastric varices.
机译:背景:保留脾脏的远端胰腺切除术可以通过保留脾脏血管(SPDP-SVP)或脾脏血管切除术(SPDP-SVR)来进行。这项荟萃分析旨在评估接受SPDP-SVP或SPDP-SVR的患者的临床结局。方法:对PubMed,Embase和Cochrane库进行系统的文献检索。评估了手术时间,估计的失血量,术后并发症,胰瘘(B + C级),脾梗塞率,胃/咽峡静脉曲张率和术后住院时间。 RevMan 5.3软件用于评估组之间的差异。结果:该荟萃分析包括9项研究,涉及639例患者,其中402例接受SPDP-SVP,237例接受SPDP-SVR。接受SPDP-SVP的患者脾脏梗死率较低,胃/胃曲张静脉曲张发生率更低。两组患者的手术时间,估计失血量,术后并发症,胰瘘(B + C级)发生率和术后住院时间相当。结论:SPDP-SVP和SPDP-SVR都是处理良性或低度恶性胰腺体或尾部肿瘤的安全,可行的程序。然而,SPDP-SVR与早期脾缺血和胃/ perigastric静脉曲张的高发病率有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号